Projects per year
Personal profile
Personal profile
Dr. Eleftherios Mylonakis, is Chair of Department of Medicine at Houston Methodist Hospital. Prior to joining HMH, Dr. Mylonakis was Charles C.J. Carpenter Professor of Infectious Disease and. Chief of Infectious Diseases at the Warren Alpert Medical School of Brown University where he was also Professor of Molecular Microbiology and Immunology and Assistant Dean for Longitudinal Medical Research. Prior to his 10 years at Brown, Dr. Mylonakis was Attending Physician at Massachusetts General Hospital and rose through the ranks at Harvard Medical School up to Associate Professor.
Research interests
Dr. Mylonakis studies host and microbial factors of infection and the discovery of antimicrobial agents. His research encompasses both clinical and laboratory studies and the use of mammalian and invertebrate model hosts systems to identify novel antimicrobial compounds and the elucidation of evolutionarily conserved aspects of microbial virulence and the host response. He has eight patents, has edited five books, and published over 450 articles in the peer-reviewed literature.
External positions
Professor of Medicine, Weill Cornell Medical College
Jul 1 2023 → …
Research Area Keywords
- Infectious Disease & Pathology
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Natural Phenolic Compounds against Oral Candidiasis (OC)
8/9/24 → 7/31/29
Project: Federal Funding Agencies
-
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
4/30/24 → 12/31/24
Project: Federal Funding Agencies
-
Structural and functional alterations in mitochondria of patients with multi-organ injury and sepsis
Gotur, D. B., Hamilton, D. J. & Mylonakis, E.
4/3/24 → …
Project: Clinical Trial
-
A transformative platform to combat antibiotic resistant bacteria.
9/26/23 → 9/25/28
Project: Federal Funding Agencies
-
A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin
Heo, H. Y., Zou, G., Baek, S., Kim, J. S., Mylonakis, E., Ausubel, F. M., Gao, H. & Kim, W., Mar 6 2024, In: Advanced Science. 11, 9, p. e2306112 2306112.Research output: Contribution to journal › Article › peer-review
Open Access -
Cumulative incidence and mortality rate of cardiovascular complications due to laboratory-confirmed influenza virus infection: A systematic review and meta-analysis
Ouranos, K., Vassilopoulos, S., Vassilopoulos, A., Shehadeh, F. & Mylonakis, E., Jan 2024, In: Reviews in Medical Virology. 34, 1, p. e2497 e2497.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis
Ouranos, K., Avila, D. V., Mylona, E. K., Vassilopoulos, A., Vassilopoulos, S., Shehadeh, F. & Mylonakis, E., Jul 2024, In: PLoS ONE. 19, 7 July, e0306548.Research output: Contribution to journal › Article › peer-review
Open Access -
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
ACTIV-3/TICO Study Group, Jun 2024, In: The Lancet Microbe. 5, 6, p. e559-e569Research output: Contribution to journal › Article › peer-review
Open Access -
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
ACTIV-3/TICO Study Group, Jun 2024, In: The Lancet Microbe. 5, 6, p. e559-e569Research output: Contribution to journal › Article › peer-review